解决与自体主导高IgE综合征相关的持续性空气泄漏,使用单向内支气管:病例报告
John Kucera1, Munir Buhaya2, Nicole Nix Sartain3
1Department of Surgery, Walter Reed National Military Medical Center, Bethesda, MD, USA.
AME case reports
|May 7, 2024
概括
胸内膜 (EBV) 为患有自身主导性超IgE综合征 (AD-HIES) 患者的持续性空气泄漏 (PALs) 提供了一种新的治疗方法. 这种方法在两个复杂的案例中成功解决了PALs,证明了EBV作为一种有价值的治疗选择.
科学领域:
- 肺部病理学 肺部病理学
- 遗传学 是一个遗传学.
- 胸部外科手术 胸部外科手术
背景情况:
- 自体主导的超IgE综合征 (AD-HIES) 是一种罕见的遗传疾病,影响伤口愈合.
- 患有AD-HIES的患者容易患上由支气管多气引起的持续性空气泄漏 (PALs).
- 在AD-HIES患者中管理PAL存在独特的临床挑战.
研究的目的:
- 描述AD-HIES患者PAL的新管理策略.
- 为了评估内支气管 (EBVs) 在这种人群中治疗PAL的疗效和安全性.
主要方法:
- 对两名患有PALs的AD-HIES患者的回顾性审查.
- 内部支气管 (EBV) 的部署,以管理持续的空气泄漏.
- 对治疗成功和不良事件的监测.
主要成果:
- 两名患有复杂PAL的AD-HIES患者被EBVs成功治疗.
- 由于空气泄漏的复杂性,最初的EBV安置需要在一个患者身上进行多次尝试.
- 两名患者在EBV治疗后经历了PALs的消失,没有进展性感染.
结论:
- 胸内膜 (EBVs) 有效地管理自体主导高IgE综合征 (AD-HIES) 患者的持续性空气泄漏 (PALs).
- 在这种复杂的遗传条件下,EBVs代表了反抗性PALs治疗选择的宝贵补充.
- 在AD-HIES患者中,EBV治疗耐受性良好,这表明其安全性.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
277
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
277
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:20Asthma: Pathogenesis and Management
389
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
389
01:29Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
01:26Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
01:17Drugs Used in Lower Respiratory Disorders: Overview
424
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
424